CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC

Clinical trial NCT07449065 · COMPLETED

Trial details

NCT number: NCT07449065
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma (HCC)Transarterial Chemoembolization Microvascular Invasion (MVI)Tyrosine Kinase Inhibitors

Start date: 2018-06-01
Primary completion: 2025-10-31
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.